AtriCure, Inc. provided earnings guidance for 2024. For Full year 2024 revenue is projected to be approximately $459 million to $466 million, reflecting growth of approximately 15% to 17% over full year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.89 USD | -2.58% | +0.09% | -38.67% |
02/05 | Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating | MT |
01/05 | Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, vs. Street Est of $106.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.67% | 1.06B | |
-5.51% | 181B | |
+2.33% | 112B | |
-3.62% | 67.92B | |
+1.52% | 50.1B | |
+8.06% | 44.27B | |
+7.74% | 40.41B | |
+23.35% | 31.95B | |
+0.67% | 25.82B | |
+17.61% | 25.29B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- Atricure, Inc. Provides Earnings Guidance for 2024